113 related articles for article (PubMed ID: 9169102)
1. Serotonin decreases cytoskeletal and cytosolic glycolytic enzymes and the levels of ATP and glucose 1,6-bisphosphate in skin, which is prevented by the calmodulin antagonists thioridazine and clotrimazole.
Ashkenazy-Shahar M; Beitner R
Biochem Mol Med; 1997 Apr; 60(2):187-93. PubMed ID: 9169102
[TBL] [Abstract][Full Text] [Related]
2. Effects of Ca(2+)-ionophore A23187 and calmodulin antagonists on regulatory mechanisms of glycolysis and cell viability of NIH-3T3 fibroblasts.
Ashkenazy-Shahar M; Beitner R
Mol Genet Metab; 1999 Aug; 67(4):334-42. PubMed ID: 10444344
[TBL] [Abstract][Full Text] [Related]
3. Serotonin-induced decrease in brain ATP, stimulation of brain anaerobic glycolysis and elevation of plasma hemoglobin; the protective action of calmodulin antagonists.
Koren-Schwartzer N; Chen-Zion M; Ben-Porat H; Beitner R
Gen Pharmacol; 1994 Oct; 25(6):1257-62. PubMed ID: 7875554
[TBL] [Abstract][Full Text] [Related]
4. Insulin stimulates binding of phosphofructokinase to cytoskeleton and increases glucose 1,6-bisphosphate levels in NIH-3T3 fibroblasts, which is prevented by calmodulin antagonists.
Ashkenazy-Shahar M; Ben-Porat H; Beitner R
Mol Genet Metab; 1998 Nov; 65(3):213-9. PubMed ID: 9851886
[TBL] [Abstract][Full Text] [Related]
5. Calmodulin antagonists decrease glucose 1,6-bisphosphate, fructose 1,6-bisphosphate, ATP and viability of melanoma cells.
Glass-Marmor L; Morgenstern H; Beitner R
Eur J Pharmacol; 1996 Oct; 313(3):265-71. PubMed ID: 8911923
[TBL] [Abstract][Full Text] [Related]
6. Detachment of glycolytic enzymes from cytoskeleton of melanoma cells induced by calmodulin antagonists.
Glass-Marmor L; Beitner R
Eur J Pharmacol; 1997 Jun; 328(2-3):241-8. PubMed ID: 9218707
[TBL] [Abstract][Full Text] [Related]
7. Treatment of muscle damage, induced by high intracellular Ca2+, with calmodulin antagonists.
Beitner R; Lilling G
Gen Pharmacol; 1993 Jul; 24(4):847-55. PubMed ID: 8224738
[TBL] [Abstract][Full Text] [Related]
8. Clotrimazole decreases glycolysis and the viability of lung carcinoma and colon adenocarcinoma cells.
Penso J; Beitner R
Eur J Pharmacol; 2002 Sep; 451(3):227-35. PubMed ID: 12242083
[TBL] [Abstract][Full Text] [Related]
9. Sequence of insulin effects on cytoskeletal and cytosolic phosphofructokinase, mitochondrial hexokinase, glucose 1,6-bisphosphate and fructose 2,6-bisphosphate levels, and the antagonistic action of calmodulin inhibitors, in diaphragm muscle.
Chen-Zion M; Bassukevitz Y; Beitner R
Int J Biochem; 1992 Oct; 24(10):1661-7. PubMed ID: 1397493
[TBL] [Abstract][Full Text] [Related]
10. Detachment of glycolytic enzymes from cytoskeleton of Lewis lung carcinoma and colon adenocarcinoma cells induced by clotrimazole and its correlation to cell viability and morphology.
Penso J; Beitner R
Mol Genet Metab; 2002 Jul; 76(3):181-8. PubMed ID: 12126931
[TBL] [Abstract][Full Text] [Related]
11. Taxol (paclitaxel) induces a detachment of phosphofructokinase from cytoskeleton of melanoma cells and decreases the levels of glucose 1,6-bisphosphate, fructose 1,6-bisphosphate and ATP.
Glass-Marmor L; Beitner R
Eur J Pharmacol; 1999 Apr; 370(2):195-9. PubMed ID: 10323269
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor (PDGF) rapidly stimulates binding of glycolytic enzymes to muscle cytoskeleton, prevented by calmodulin antagonists.
Livnat T; Chen-Zion M; Beitner R
Biochem Med Metab Biol; 1994 Oct; 53(1):28-33. PubMed ID: 7857679
[TBL] [Abstract][Full Text] [Related]
13. Stimulatory effect of epidermal growth factor on binding of glycolytic enzymes to muscles cytoskeleton and the antagonistic action of calmodulin inhibitors.
Livnat T; Chen-Zion M; Beitner R
Biochem Med Metab Biol; 1993 Aug; 50(1):24-34. PubMed ID: 8373634
[TBL] [Abstract][Full Text] [Related]
14. The dual effects of Ca2+ on binding of the glycolytic enzymes, phosphofructokinase and aldolase, to muscle cytoskeleton.
Chen-Zion M; Lilling G; Beitner R
Biochem Med Metab Biol; 1993 Apr; 49(2):173-81. PubMed ID: 8484959
[TBL] [Abstract][Full Text] [Related]
15. Clotrimazole inhibits and modulates heterologous association of the key glycolytic enzyme 6-phosphofructo-1-kinase.
Zancan P; Rosas AO; Marcondes MC; Marinho-Carvalho MM; Sola-Penna M
Biochem Pharmacol; 2007 May; 73(10):1520-7. PubMed ID: 17291460
[TBL] [Abstract][Full Text] [Related]
16. Effects of carbamylcholine and pyridostigmine on cytoskeleton-bound and cytosolic phosphofructokinase and ATP levels in different rat tissues.
Glass-Marmor L; Chen-Zion M; Beitner R
Gen Pharmacol; 1996 Oct; 27(7):1241-6. PubMed ID: 8981075
[TBL] [Abstract][Full Text] [Related]
17. Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes.
Meira DD; Marinho-Carvalho MM; Teixeira CA; Veiga VF; Da Poian AT; Holandino C; de Freitas MS; Sola-Penna M
Mol Genet Metab; 2005 Apr; 84(4):354-62. PubMed ID: 15781197
[TBL] [Abstract][Full Text] [Related]
18. Effect of insulin-induced hypoglycemia on cytoskeleton-bound and cytosolic phosphofructokinase and the levels of glucose 1,6-bisphosphate in rat brain.
Magen A; Koren-Schwartzer N; Chen-Zion M; Beitner R
Biochem Mol Med; 1995 Dec; 56(2):94-8. PubMed ID: 8825070
[TBL] [Abstract][Full Text] [Related]
19. Calmodulin and dynamics of interactions of cytosolic enzymes.
Ovádi J; Orosz F
Curr Top Cell Regul; 1992; 33():105-26. PubMed ID: 1386799
[No Abstract] [Full Text] [Related]
20. Therapeutic and prophylactic treatment of skin burns with several calmodulin antagonists.
Beitner R; Chen-Zion M; Sofer-Bassukevitz Y; Oster Y; Ben-Porat H; Morgenstern H
Gen Pharmacol; 1989; 20(2):165-73. PubMed ID: 2714615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
